COMMON STI571: A COST-EFFECTIVE OPTION?

The arrival of common imatinib represents a notable chance for patients battling CML and other illnesses. Original brand-name imatinib, often referred to as Gleevec, carries a considerable price label, frequently causing accessibility for some individuals. Generic versions, usually manufactured b